Risk of bias analysis in diabetic retinopathy randomized clinical trials evaluated by RoB-1 tool from Cochrane systematic reviews
The objective of clinical trials is to answer about intervention in the real-world, for which they must be properly designed and executed by presenting the results reliably with the findings and in a clear way. OBJECTIVES: To identify the risk of bias in clinical trials about interventions for diab...
Main Authors: | Vânia Mozetic, Valéria Barros, Lucas Denadai, Nilva Simeren Bueno de Moraes |
---|---|
Format: | Article |
Language: | English |
Published: |
Escola Bahiana de Medicina e Saúde Pública
2022-04-01
|
Series: | Journal of Evidence-Based Healthcare |
Subjects: | |
Online Access: | https://www5.bahiana.edu.br/index.php/evidence/article/view/3791 |
Similar Items
-
Bias and unclear outcomes in clinical trials of diabetic retinopathy: a cross-sectional analysis of literature
by: Vania Mozetic, et al.
Published: (2022-01-01) -
A warning to readers about the term metanalysis in non-systematic reviews about diabetic retinopathy: documental study
by: Vania Mozetic, et al.
Published: (2021-03-01) -
Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy
by: Ines P. Marques, et al.
Published: (2020-05-01) -
Macular oedema as manifestation of diabetic retinopathy
by: Mukharram M. Bikbov, et al.
Published: (2017-10-01) -
Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
by: Ribeiro de Carvalho G, et al.
Published: (2020-09-01)